Shih PC, Hung PC, Leong PY, Hsu JN, et al. Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study. Clin Rheumatol 2024 Oct 11. doi: 10.1007/s10067-024-07161.
PMID: 39392514